Abstract
Presentamos una mujer de 42 años quien consultó por parestesia lingual y ganancia de 10 Kg de peso, sin síntomas clásicos de hipoglucemia, a quién se le encontró una glucemia en ayunas de 46 mg/dl (2,6 mmol/L) con insulina y péptido C concomitantes de 10,2 µU/ml (73,2 pmol/L) y 2,14 ng/dl (79,2 nmol/L) respectivamente. Hallazgos similares fueron encontrados en una segunda ocasión. La resonancia magnética del páncreas mostró una lesión de 1,7 x 1,3 cm dependiente del reborde superior del cuerpo, la cual fue extirpada vía laparoscopia. Patología reveló un tumor neuroendocrino con inmunohistoquímica positiva para insulina, cromogranina y sinaptofisina. La parestesia lingual desapareció y la glucosa se normalizó. La tríada de Whipple no siempre está presente en pacientes con hipoglucemia, mientras que la parestesia lingual debe considerarse para la evaluación de estos pacientes.
Abstract
We report on a 42 years old female who consulted because of lingual paresthesia and 10 kg weight gain but without classic symptoms of hypoglycemia, who had a fasting blood glucose of 46 mg/dl (2.6 mmol/L) with a concomitant insulin a C-peptide of 10.2 µU/ml (73.2 pmol/L) and 2.14 ng/dl (79.2 nmol/L) respectively. Similar findings were obtained on a second occasion. Magnetic resonance of the pancreas revealed a 1.7 x 1.3 cm lesion dependent of the superior border of the body which was removed by laparoscopy.
Pathology showed a neuroendocrine tumor with positive immmunohistochemistry for insulin, chromogranin and synaptophysin. Lingual paresthesia disappeared and blood glucose was normalized. Patients with lingual paresthesia should be evaluated for hypoglycemia even in the absent of a classic Whipple triad.
References
2. Cryer P 2001. The prevention and correction of hypoglycemia. In: Jefferson L, Cherrington A, Goodman H eds Handbook of Physiology ; Section7, the endocrine system. Volume 2. The endocrine pancreas and regulation of metabolism. New York : Oxford University Press; 1057-1092.
3. Service FJ, Dale AJ, Elveback LR et al. Insulinoma. Clinical and diagnostic features of 60 consecutive cases. Mayo Clinic proc 1976 Jul; 51(7): 417-429.
4. Jácome Roca A, Espinosa H, Echeverry G, Escallón A, Baena M. Insulinoma, demostración de hiperinsulinismo y localización preoperatoria: Manejo Quirurgico. Univmed 1983; 25 (1): 28-35.
5. Placzkowski KA, Vella A, Thompson GB et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987- 2007. J ClinEndocrinolMetab 2009 Apr; 94(4): 1069-1073.
6. Cryer PE, Axelrod L, Grossman AB et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guide- line. J ClinEndocrinolMetab 2009 Mar; 94(3): 709-728.
Authors must state that they reviewed, validated and approved the manuscript's publication. Moreover, they must sign a model release that should be sent. A copy may be reviewed here